Epidemiology, Treatment, and Performance-Based Outcomes in American Professional Baseball Players With Symptomatic Spondylolysis and Isthmic Spondylolisthesis.

MLA

Gould, Heath P., et al. “Epidemiology, Treatment, and Performance-Based Outcomes in American Professional Baseball Players With Symptomatic Spondylolysis and Isthmic Spondylolisthesis.” American Journal of Sports Medicine, vol. 48, no. 11, Sept. 2020, pp. 2765–73. EBSCOhost, https://doi.org/10.1177/0363546520945727.

APA

Gould, H. P., Winkelman, R. D., Tanenbaum, J. E., Hu, E., Haines, C. M., Hsu, W. K., Kalfas, I. H., Savage, J. W., Schickendantz, M. S., & Mroz, T. E. (2020). Epidemiology, Treatment, and Performance-Based Outcomes in American Professional Baseball Players With Symptomatic Spondylolysis and Isthmic Spondylolisthesis. American Journal of Sports Medicine, 48(11), 2765–2773. https://doi.org/10.1177/0363546520945727

Chicago

Gould, Heath P., Robert D. Winkelman, Joseph E. Tanenbaum, Emily Hu, Colin M. Haines, Wellington K. Hsu, Iain H. Kalfas, Jason W. Savage, Mark S. Schickendantz, and Thomas E. Mroz. 2020. “Epidemiology, Treatment, and Performance-Based Outcomes in American Professional Baseball Players With Symptomatic Spondylolysis and Isthmic Spondylolisthesis.” American Journal of Sports Medicine 48 (11): 2765–73. doi:10.1177/0363546520945727.